Clinical trial
Drug-Induced Liver Injury (DILI) Network Retrospective
NCT00360646 · Duke University, Other · Recruiting
Key facts
| NCT number | NCT00360646 |
|---|---|
| Title | Drug-Induced Liver Injury (DILI) Network Retrospective |
| Official title | Idiosyncratic Liver Injury Associated With Drugs (ILIAD): A Retrospective Study |
| Acronym | ILIAD |
| Lead sponsor | Duke University, Other |
| Collaborators | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH |
| Status | Recruiting |
| Study type | Observational |
| Conditions | Drug Induced Liver Injury |
| Enrollment | 400 |
| Start date | Sep 1, 2004 |
| Primary completion | Jul 31, 2028 |
| Completion | Jul 31, 2028 |
| First posted | Aug 4, 2006 |
| Last update posted | Apr 20, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: